Optimi Health (OPTH) Stock Price, News & Analysis

Company Overview

Optimi Health Corp. is a Canadian life sciences company focused on the development and production of psychedelic and functional mushroom products. The company’s work centers on naturally sourced compounds, including psilocybin, for potential applications in mental health and wellness.

Optimi operates a production and research facility in Princeton, British Columbia, where it develops mushroom-based formulations and related products. Its activities have included the cultivation, extraction, formulation and packaging of products intended for clinical research, therapeutic development and consumer wellness markets, subject to applicable regulatory requirements.

The company serves customers and research partners primarily from Canada and is also focused on opportunities in international markets as regulations governing psychedelic medicines and mushroom-derived products evolve. Optimi Health is led by Chief Executive Officer Bill Ciprick, who has been associated with the company since its early development.

Key Stats

• Today's Range: $4.00 to $4.20
• 50-Day Range: $4.02 to $5.15
• 52-Week Range: $4.00 to $6.40
• Volume: 21,409 shs
• Average Volume: 44,528 shs
• Market Capitalization: $23.03 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Reduce

Optimi Health Stock Analysis - MarketRank™

Optimi Health scored higher than 7% of companies evaluated by MarketBeat, and ranked 866th out of 882 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Reduce

Consensus Rating

Optimi Health has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

Optimi Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Optimi Health is -5.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Optimi Health is -5.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.51% of the float of Optimi Health has been sold short.

Short Interest Ratio / Days to Cover

Optimi Health has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Optimi Health has recently increased by 43.67%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Optimi Health does not currently pay a dividend.

Dividend Growth

Optimi Health does not have a long track record of dividend growth.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: 0.60

News Sentiment

Optimi Health has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Optimi Health this week, compared to 3 articles on an average week.

MarketBeat Follows

Only 1 people have added Optimi Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Optimi Health insiders have not sold or bought any company stock.

Percentage Held by Institutions

Optimi Health has minimal institutional ownership at this time.

Company Calendar

• Today: 10/11/2026
• The ThinkEquity Conference: 10/15/2026
• Fiscal Year End: 9/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:OPTH
• CIK: 2027329
• Web: www.optimihealth.ca
• Phone: 778-761-4551
• Fax: N/A
• Employees: 9
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.04
• Current Ratio: 0.06
• Quick Ratio: 0.03

Sales & Book Value

• Annual Sales: $310 thousand
• Price / Sales: 74.31
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 5,730,000
• Free Float: N/A
• Market Cap: $23.03 million
• Optionable: N/A
• Beta: N/A